Development of 5-phenylnitro bearing furan-based chalcones as a new class of potent MAO-B inhibitors
Our results revealed that KD1 and KD9 are potent selective, reversible, and competitive MAO-B inhibitors.
Authors
- Raihan Arikkattel Abdu
- Sunil Kumar (ORCID: https://orcid.org/0009-0009-3354-0322)
- Abdallah Mohamed Elgorban (ORCID: https://orcid.org/0000-0003-3664-7853)
- Kadeeja Thottungal Kalathil
- Bishnu Prasad Pandey (ORCID: https://orcid.org/0000-0002-3244-8796)
- Sanal Dev (ORCID: https://orcid.org/0000-0002-4128-8413)
- Alanoud T. Alfagham (ORCID: https://orcid.org/0000-0001-9008-3679)
- Arshida Thottile Peedikayil
- Hoon Kim (ORCID: https://orcid.org/0000-0002-7203-3712)
- Bijo Mathew
- Rajasree Raghavan Sreekumari
Institutions
- Sunchon National University (KR)
- King Saud University (SA)
- T. D. Medical College (IN)
- Kerala University of Health Sciences (IN)
- Kathmandu University (NP)
- Amrita Vishwa Vidyapeetham (IN)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/17568919.2025.2485671
- Citations
- 1
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- King Saud University